345 related articles for article (PubMed ID: 24661212)
1. UCSF Small Molecule Discovery Center: innovation, collaboration and chemical biology in the Bay Area.
Arkin MR; Ang KK; Chen S; Davies J; Merron C; Tang Y; Wilson CG; Renslo AR
Comb Chem High Throughput Screen; 2014 May; 17(4):333-42. PubMed ID: 24661212
[TBL] [Abstract][Full Text] [Related]
2. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
3. From HTS to Phase I: the Institute for Therapeutics Discovery and Development at the University of Minnesota.
Dosa PI; Georg GI; Gurvich VJ; Hawkinson JE; Walters MA; Wong HL
Comb Chem High Throughput Screen; 2014 Mar; 17(3):231-40. PubMed ID: 24409956
[TBL] [Abstract][Full Text] [Related]
4. The role of HTS in drug discovery at the University of Michigan.
Larsen MJ; Larsen SD; Fribley A; Grembecka J; Homan K; Mapp A; Haak A; Nikolovska-Coleska Z; Stuckey JA; Sun D; Sherman DH
Comb Chem High Throughput Screen; 2014 Mar; 17(3):210-30. PubMed ID: 24409957
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting caspase-6 activation and catalytic activity for neurodegenerative diseases.
Flygare JA; Arkin MR
Curr Top Med Chem; 2014; 14(3):319-25. PubMed ID: 24283214
[TBL] [Abstract][Full Text] [Related]
6. The Emory Chemical Biology Discovery Center: leveraging academic innovation to advance novel targets through HTS and beyond.
Johns MA; Meyerkord-Belton CL; Du Y; Fu H
Comb Chem High Throughput Screen; 2014 Mar; 17(3):290-6. PubMed ID: 24409950
[TBL] [Abstract][Full Text] [Related]
7. Integration of small-molecule discovery in academic biomedical research.
Ohlmeyer M; Zhou MM
Mt Sinai J Med; 2010; 77(4):350-7. PubMed ID: 20687180
[TBL] [Abstract][Full Text] [Related]
8. UCLA's Molecular Screening Shared Resource: enhancing small molecule discovery with functional genomics and new technology.
Damoiseaux R
Comb Chem High Throughput Screen; 2014 May; 17(4):356-68. PubMed ID: 24661210
[TBL] [Abstract][Full Text] [Related]
9. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
10. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
11. High throughput screening operations at the University of Kansas.
Roy A
Comb Chem High Throughput Screen; 2014 May; 17(4):387-93. PubMed ID: 24661207
[TBL] [Abstract][Full Text] [Related]
12. A perspective on 10-years HTS experience at the Walter and Eliza Hall Institute of Medical Research - eighteen million assays and counting.
Lackovic K; Lessene G; Falk H; Leuchowius KJ; Baell J; Street I
Comb Chem High Throughput Screen; 2014 Mar; 17(3):241-52. PubMed ID: 24409955
[TBL] [Abstract][Full Text] [Related]
13. Lead identification to clinical candidate selection: drugs for Chagas disease.
Neitz RJ; Chen S; Supek F; Yeh V; Kellar D; Gut J; Bryant C; Gallardo-Godoy A; Molteni V; Roach SL; Khare S; Stinson M; Chatterjee AK; Robertson S; Renslo AR; Arkin M; Glynne R; McKerrow J; Siqueira-Neto JL
J Biomol Screen; 2015 Jan; 20(1):101-11. PubMed ID: 25281737
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
[TBL] [Abstract][Full Text] [Related]
15. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
[TBL] [Abstract][Full Text] [Related]
16. Fragment-based approaches in drug discovery and chemical biology.
Scott DE; Coyne AG; Hudson SA; Abell C
Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
[TBL] [Abstract][Full Text] [Related]
17. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
[TBL] [Abstract][Full Text] [Related]
18. The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology.
McDonald PR; Roy A; Chaguturu R
Future Med Chem; 2011 Jul; 3(9):1101-10. PubMed ID: 21806374
[TBL] [Abstract][Full Text] [Related]
19. An Analysis of Different Components of a High-Throughput Screening Library.
Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
